StockData
Cabaletta Bio, Inc. logo

Cabaletta Bio, Inc. (CABA) stock

CABANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 2/30
$1.05+0.03 (+3.43%)

Close on Nov 18, 2026Market cap $178.87MP/E –Yield –

Cabaletta Bio gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Cabaletta Bio

Cabaletta Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Cabaletta Bio figures

See a number that looks wrong?